Anavex schedules Sept. 9 investor call to outline clinical development strategy and priorities
AVXL•Investor call scheduled for Sept. 9
Anavex plans an investor call at 4:00 PM ET on Sept. 9, 2026 to outline clinical development strategy priorities.
Interim CEO Terrie Kellmeyer will present the company’s forward clinical development planning.
